Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Allison

Showing results (11-20 of 602) with videos related to

Pageof 61
Sort By:
Experimental Gerontology|October 31, 2016
Perspectives in aging: Nutritional and energetic interventionsSteven N Austad, David B Allison
JAMA|September 20, 2012
FDA approval of obesity drugs: a difference in risk-benefit perceptionsElaine H Morrato, David B Allison
The Journal of Clinical Endocrinology and Metabolism|October 8, 2025
Unraveling Obesity with the Multi-Omics Score: From Solo to OrchestraHari Krishna Yalamanchili, David B Allison
Behavior Genetics|March 4, 2006
The effect of assortative mating upon genetic association studies: spurious associations and population substructure in the absence of admixtureDavid T Redden, David B Allison
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 2, 2002
Two-stage testing in microarray analysis: what is gained?David B Allison, Christopher S Coffey
Nature Human Behaviour|December 11, 2024
Report uncertainty information to improve trust in scienceRaul Cruz-Cano, David B Allison
Nutrition Journal|June 7, 2016
Inappropriate statistical method in a parallel-group randomized controlled trial results in unsubstantiated conclusionsRositsa B Dimova, David B Allison
Obesity (Silver Spring, Md.)|August 26, 2006
Obesity: person and populationMark B Cope, David B Allison
Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2004
Rimonabant Sanofi-SynthélaboJose R Fernandez, David B Allison
Lancet (London, England)|November 19, 2021
Long-acting amylin analogue for weight reductionKishore M Gadde, David B Allison
Pageof 61

Showing results (11-20 of 602) with videos related to

Sort By:
Pageof 61
Experimental Gerontology|October 31, 2016
Perspectives in aging: Nutritional and energetic interventionsSteven N Austad, David B Allison
JAMA|September 20, 2012
FDA approval of obesity drugs: a difference in risk-benefit perceptionsElaine H Morrato, David B Allison
The Journal of Clinical Endocrinology and Metabolism|October 8, 2025
Unraveling Obesity with the Multi-Omics Score: From Solo to OrchestraHari Krishna Yalamanchili, David B Allison
Behavior Genetics|March 4, 2006
The effect of assortative mating upon genetic association studies: spurious associations and population substructure in the absence of admixtureDavid T Redden, David B Allison
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 2, 2002
Two-stage testing in microarray analysis: what is gained?David B Allison, Christopher S Coffey
Nature Human Behaviour|December 11, 2024
Report uncertainty information to improve trust in scienceRaul Cruz-Cano, David B Allison
Nutrition Journal|June 7, 2016
Inappropriate statistical method in a parallel-group randomized controlled trial results in unsubstantiated conclusionsRositsa B Dimova, David B Allison
Obesity (Silver Spring, Md.)|August 26, 2006
Obesity: person and populationMark B Cope, David B Allison
Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2004
Rimonabant Sanofi-SynthélaboJose R Fernandez, David B Allison
Lancet (London, England)|November 19, 2021
Long-acting amylin analogue for weight reductionKishore M Gadde, David B Allison
Pageof 61